Shopping Cart
- Remove All
- Your shopping cart is currently empty
RVG29-Cys is a peptide derived from rabies virus glycoprotein (RVG) that specifically binds to nicotinic acetylcholine receptors (nAchR) on neural cells. It is employed to functionalize lipid nanoparticles (LNPs) via thiol-maleimide click chemistry for targeting nAchR present on the blood-brain barrier (BBB). mRNA LNPs functionalized with RVG29-Cys demonstrate enhanced transfection efficiency in cultured brain endothelial and neuronal cells, as well as in mice following systemic administration.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | RVG29-Cys is a peptide derived from rabies virus glycoprotein (RVG) that specifically binds to nicotinic acetylcholine receptors (nAchR) on neural cells. It is employed to functionalize lipid nanoparticles (LNPs) via thiol-maleimide click chemistry for targeting nAchR present on the blood-brain barrier (BBB). mRNA LNPs functionalized with RVG29-Cys demonstrate enhanced transfection efficiency in cultured brain endothelial and neuronal cells, as well as in mice following systemic administration. |
In vitro | RVG29-Cys is a peptide originating from rabies virus glycoprotein (RVG) that specifically targets nicotinic acetylcholine receptors (nAchR) on neuronal cells. It is utilized to functionalize lipid nanoparticles (LNPs) through thiol-maleimide click chemistry, facilitating nAchR targeting on the blood-brain barrier (BBB). mRNA LNPs enhanced with RVG29-Cys exhibit increased transfection efficiency in both cultured brain endothelial and neuronal cells, as well as in vivo following systemic administration in mice. |
Cas No. | 1404289-25-3 |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.